Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 157 to 163 of 163 entries
Sorted by: Best Match Show Resources per page
Difficult-To-Control Asthma Management In Adults.

The journal of allergy and clinical immunology. In practice

Menzies-Gow A, Moore WC, Wechsler ME.
PMID: 34954122
J Allergy Clin Immunol Pract. 2021 Dec 22; doi: 10.1016/j.jaip.2021.12.007. Epub 2021 Dec 22.

The management of difficult to control asthma remains a significant challenge, which frequently requires the input of the wider multi-disciplinary team. This review will cover the importance of systematic assessment, phenotyping, treatment options at step 4, an overview of...

Cite
Menzies-Gow A, Moore WC, Wechsler ME. Difficult-To-Control Asthma Management In Adults. J Allergy Clin Immunol Pract. 2021;doi: 10.1016/j.jaip.2021.12.007.
Menzies-Gow, A., Moore, W. C., & Wechsler, M. E. (2021). Difficult-To-Control Asthma Management In Adults. The journal of allergy and clinical immunology. In practice, . https://doi.org/10.1016/j.jaip.2021.12.007
Menzies-Gow, Andrew, et al. "Difficult-To-Control Asthma Management In Adults." The journal of allergy and clinical immunology. In practice vol. (2021). doi: https://doi.org/10.1016/j.jaip.2021.12.007
Menzies-Gow A, Moore WC, Wechsler ME. Difficult-To-Control Asthma Management In Adults. J Allergy Clin Immunol Pract. 2021 Dec 22; doi: 10.1016/j.jaip.2021.12.007. Epub 2021 Dec 22. PMID: 34954122.
Copy Download .nbib Format: NLM
Case report of transplant renal artery stenosis secondary to mechanical renal artery kinking: Balloon angioplasty as a supportive diagnostic tool?.

International journal of surgery case reports

DeVries BL, Wechsler B, Yim D.
PMID: 34098190
Int J Surg Case Rep. 2021 Jun;83:106052. doi: 10.1016/j.ijscr.2021.106052. Epub 2021 May 29.

INTRODUCTION AND IMPORTANCE: Renal vascular complications are a significant cause of morbidity in living donor renal transplantation. Among renal vascular complications, transplant renal artery stenosis (TRAS) secondary to mechanical kinking is a rare but important cause of early graft...

Cite
DeVries BL, Wechsler B, Yim D. Case report of transplant renal artery stenosis secondary to mechanical renal artery kinking: Balloon angioplasty as a supportive diagnostic tool?. Int J Surg Case Rep. 2021;83:106052doi: 10.1016/j.ijscr.2021.106052.
DeVries, B. L., Wechsler, B., & Yim, D. (2021). Case report of transplant renal artery stenosis secondary to mechanical renal artery kinking: Balloon angioplasty as a supportive diagnostic tool?. International journal of surgery case reports, 83106052. https://doi.org/10.1016/j.ijscr.2021.106052
DeVries, Brooklyn L, et al. "Case report of transplant renal artery stenosis secondary to mechanical renal artery kinking: Balloon angioplasty as a supportive diagnostic tool?." International journal of surgery case reports vol. 83 (2021): 106052. doi: https://doi.org/10.1016/j.ijscr.2021.106052
DeVries BL, Wechsler B, Yim D. Case report of transplant renal artery stenosis secondary to mechanical renal artery kinking: Balloon angioplasty as a supportive diagnostic tool?. Int J Surg Case Rep. 2021 Jun;83:106052. doi: 10.1016/j.ijscr.2021.106052. Epub 2021 May 29. PMID: 34098190; PMCID: PMC8187818.
Copy Download .nbib Format: NLM
Long-term safety and efficacy of dupilumab in patients with moderate-to-severe asthma (TRAVERSE): an open-label extension study.

The Lancet. Respiratory medicine

Wechsler ME, Ford LB, Maspero JF, Pavord ID, Papi A, Bourdin A, Watz H, Castro M, Nenasheva NM, Tohda Y, Langton D, Cardona G, Domingo C, Park HS, Chapman KR, Mao X, Zhang Y, Khan AH, Deniz Y, Rowe PJ, Kapoor U, Khokhar FA, Mannent LP, Ruddy M, Laws E, Amin N, Hardin M.
PMID: 34597534
Lancet Respir Med. 2022 Jan;10(1):11-25. doi: 10.1016/S2213-2600(21)00322-2. Epub 2021 Sep 28.

BACKGROUND: Clinical trials have shown treatment benefits of dupilumab in patients with uncontrolled asthma for up to 1 year. This study aimed to evaluate the long-term safety and efficacy of dupilumab in patients with moderate-to-severe asthma, as data for...

Cite
Wechsler ME, Ford LB, Maspero JF, et al. Long-term safety and efficacy of dupilumab in patients with moderate-to-severe asthma (TRAVERSE): an open-label extension study. Lancet Respir Med. 2021;10(1):11-25doi: 10.1016/S2213-2600(21)00322-2.
Wechsler, M. E., Ford, L. B., Maspero, J. F., Pavord, I. D., Papi, A., Bourdin, A., Watz, H., Castro, M., Nenasheva, N. M., Tohda, Y., Langton, D., Cardona, G., Domingo, C., Park, H. S., Chapman, K. R., Mao, X., Zhang, Y., Khan, A. H., Deniz, Y., Rowe, P. J., Kapoor, U., Khokhar, F. A., Mannent, L. P., Ruddy, M., Laws, E., Amin, N., & Hardin, M. (2022). Long-term safety and efficacy of dupilumab in patients with moderate-to-severe asthma (TRAVERSE): an open-label extension study. The Lancet. Respiratory medicine, 10(1), 11-25. https://doi.org/10.1016/S2213-2600(21)00322-2
Wechsler, Michael E, et al. "Long-term safety and efficacy of dupilumab in patients with moderate-to-severe asthma (TRAVERSE): an open-label extension study." The Lancet. Respiratory medicine vol. 10,1 (2022): 11-25. doi: https://doi.org/10.1016/S2213-2600(21)00322-2
Wechsler ME, Ford LB, Maspero JF, Pavord ID, Papi A, Bourdin A, Watz H, Castro M, Nenasheva NM, Tohda Y, Langton D, Cardona G, Domingo C, Park HS, Chapman KR, Mao X, Zhang Y, Khan AH, Deniz Y, Rowe PJ, Kapoor U, Khokhar FA, Mannent LP, Ruddy M, Laws E, Amin N, Hardin M. Long-term safety and efficacy of dupilumab in patients with moderate-to-severe asthma (TRAVERSE): an open-label extension study. Lancet Respir Med. 2022 Jan;10(1):11-25. doi: 10.1016/S2213-2600(21)00322-2. Epub 2021 Sep 28. PMID: 34597534.
Copy Download .nbib Format: NLM
Influence of Housing and Management on Claw Health in Swiss Dairy Goats.

Animals : an open access journal from MDPI

Sailer LM, Holinger M, Burla JB, Wechsler B, Zanolari P, Friedli K.
PMID: 34201692
Animals (Basel). 2021 Jun 23;11(7). doi: 10.3390/ani11071873.

Due to a rising demand for goat milk and goat milk products worldwide, it is likely that dairy goat production will be intensified in the future, with larger herds per farm. In Switzerland, as in many other countries with...

Cite
Sailer LM, Holinger M, Burla JB, et al. Influence of Housing and Management on Claw Health in Swiss Dairy Goats. Animals (Basel). 2021;11(7)doi: 10.3390/ani11071873.
Sailer, L. M., Holinger, M., Burla, J. B., Wechsler, B., Zanolari, P., & Friedli, K. (2021). Influence of Housing and Management on Claw Health in Swiss Dairy Goats. Animals : an open access journal from MDPI, 11(7), . https://doi.org/10.3390/ani11071873
Sailer, Lisa Marie, et al. "Influence of Housing and Management on Claw Health in Swiss Dairy Goats." Animals : an open access journal from MDPI vol. 11,7 (2021). doi: https://doi.org/10.3390/ani11071873
Sailer LM, Holinger M, Burla JB, Wechsler B, Zanolari P, Friedli K. Influence of Housing and Management on Claw Health in Swiss Dairy Goats. Animals (Basel). 2021 Jun 23;11(7). doi: 10.3390/ani11071873. PMID: 34201692; PMCID: PMC8300172.
Copy Download .nbib Format: NLM
Neonatal Malignant Tumors.

Clinics in perinatology

Wechsler DS.
PMID: 33583510
Clin Perinatol. 2021 Mar;48(1):xix-xx. doi: 10.1016/j.clp.2020.12.002. Epub 2021 Jan 12.

No abstract available.

Cite
Wechsler DS. Neonatal Malignant Tumors. Clin Perinatol. 2021;48(1):xix-xxdoi: 10.1016/j.clp.2020.12.002.
Wechsler, D. S. (2021). Neonatal Malignant Tumors. Clinics in perinatology, 48(1), xix-xx. https://doi.org/10.1016/j.clp.2020.12.002
Wechsler, Daniel S. "Neonatal Malignant Tumors." Clinics in perinatology vol. 48,1 (2021): xix-xx. doi: https://doi.org/10.1016/j.clp.2020.12.002
Wechsler DS. Neonatal Malignant Tumors. Clin Perinatol. 2021 Mar;48(1):xix-xx. doi: 10.1016/j.clp.2020.12.002. Epub 2021 Jan 12. PMID: 33583510.
Copy Download .nbib Format: NLM
Constraints on Dark Matter Properties from Observations of Milky Way Satellite Galaxies.

Physical review letters

Nadler EO, Drlica-Wagner A, Bechtol K, Mau S, Wechsler RH, Gluscevic V, Boddy K, Pace AB, Li TS, McNanna M, Riley AH, García-Bellido J, Mao YY, Green G, Burke DL, Peter A, Jain B, Abbott TMC, Aguena M, Allam S, Annis J, Avila S, Brooks D, Carrasco Kind M, Carretero J, Costanzi M, da Costa LN, De Vicente J, Desai S, Diehl HT, Doel P, Everett S, Evrard AE, Flaugher B, Frieman J, Gerdes DW, Gruen D, Gruendl RA, Gschwend J, Gutierrez G, Hinton SR, Honscheid K, Huterer D, James DJ, Krause E, Kuehn K, Kuropatkin N, Lahav O, Maia MAG, Marshall JL, Menanteau F, Miquel R, Palmese A, Paz-Chinchón F, Plazas AA, Romer AK, Sanchez E, Scarpine V, Serrano S, Sevilla-Noarbe I, Smith M, Soares-Santos M, Suchyta E, Swanson MEC, Tarle G, Tucker DL, Walker AR, Wester W.
PMID: 33750144
Phys Rev Lett. 2021 Mar 05;126(9):091101. doi: 10.1103/PhysRevLett.126.091101.

We perform a comprehensive study of Milky Way (MW) satellite galaxies to constrain the fundamental properties of dark matter (DM). This analysis fully incorporates inhomogeneities in the spatial distribution and detectability of MW satellites and marginalizes over uncertainties in...

Cite
Nadler EO, Drlica-Wagner A, Bechtol K, et al. Constraints on Dark Matter Properties from Observations of Milky Way Satellite Galaxies. Phys Rev Lett. 2021;126(9):091101doi: 10.1103/PhysRevLett.126.091101.
Nadler, E. O., Drlica-Wagner, A., Bechtol, K., Mau, S., Wechsler, R. H., Gluscevic, V., Boddy, K., Pace, A. B., Li, T. S., McNanna, M., Riley, A. H., García-Bellido, J., Mao, Y. Y., Green, G., Burke, D. L., Peter, A., Jain, B., Abbott, T. M. C., Aguena, M., Allam, S., Annis, J., Avila, S., Brooks, D., Carrasco Kind, M., Carretero, J., Costanzi, M., da Costa, L. N., De Vicente, J., Desai, S., Diehl, H. T., Doel, P., Everett, S., Evrard, A. E., Flaugher, B., Frieman, J., Gerdes, D. W., Gruen, D., Gruendl, R. A., Gschwend, J., Gutierrez, G., Hinton, S. R., Honscheid, K., Huterer, D., James, D. J., Krause, E., Kuehn, K., Kuropatkin, N., Lahav, O., Maia, M. A. G., Marshall, J. L., Menanteau, F., Miquel, R., Palmese, A., Paz-Chinchón, F., Plazas, A. A., Romer, A. K., Sanchez, E., Scarpine, V., Serrano, S., Sevilla-Noarbe, I., Smith, M., Soares-Santos, M., Suchyta, E., Swanson, M. E. C., Tarle, G., Tucker, D. L., Walker, A. R., Wester, W. (2021). Constraints on Dark Matter Properties from Observations of Milky Way Satellite Galaxies. Physical review letters, 126(9), 091101. https://doi.org/10.1103/PhysRevLett.126.091101
Nadler, E O, et al. "Constraints on Dark Matter Properties from Observations of Milky Way Satellite Galaxies." Physical review letters vol. 126,9 (2021): 091101. doi: https://doi.org/10.1103/PhysRevLett.126.091101
Nadler EO, Drlica-Wagner A, Bechtol K, Mau S, Wechsler RH, Gluscevic V, Boddy K, Pace AB, Li TS, McNanna M, Riley AH, García-Bellido J, Mao YY, Green G, Burke DL, Peter A, Jain B, Abbott TMC, Aguena M, Allam S, Annis J, Avila S, Brooks D, Carrasco Kind M, Carretero J, Costanzi M, da Costa LN, De Vicente J, Desai S, Diehl HT, Doel P, Everett S, Evrard AE, Flaugher B, Frieman J, Gerdes DW, Gruen D, Gruendl RA, Gschwend J, Gutierrez G, Hinton SR, Honscheid K, Huterer D, James DJ, Krause E, Kuehn K, Kuropatkin N, Lahav O, Maia MAG, Marshall JL, Menanteau F, Miquel R, Palmese A, Paz-Chinchón F, Plazas AA, Romer AK, Sanchez E, Scarpine V, Serrano S, Sevilla-Noarbe I, Smith M, Soares-Santos M, Suchyta E, Swanson MEC, Tarle G, Tucker DL, Walker AR, Wester W. Constraints on Dark Matter Properties from Observations of Milky Way Satellite Galaxies. Phys Rev Lett. 2021 Mar 05;126(9):091101. doi: 10.1103/PhysRevLett.126.091101. PMID: 33750144.
Copy Download .nbib Format: NLM
Safety and efficacy of itepekimab in patients with moderate-to-severe COPD: a genetic association study and randomised, double-blind, phase 2a trial.

The Lancet. Respiratory medicine

Rabe KF, Celli BR, Wechsler ME, Abdulai RM, Luo X, Boomsma MM, Staudinger H, Horowitz JE, Baras A, Ferreira MA, Ruddy MK, Nivens MC, Amin N, Weinreich DM, Yancopoulos GD, Goulaouic H.
PMID: 34302758
Lancet Respir Med. 2021 Nov;9(11):1288-1298. doi: 10.1016/S2213-2600(21)00167-3. Epub 2021 Jul 21.

BACKGROUND: Genetic data implicate IL-33 in asthma susceptibility. Itepekimab, a monoclonal antibody targeting IL-33, demonstrated clinical activity in asthma, with potential in chronic obstructive pulmonary disease (COPD). In this study we first aimed to test the hypothesis that genetic...

Cite
Rabe KF, Celli BR, Wechsler ME, et al. Safety and efficacy of itepekimab in patients with moderate-to-severe COPD: a genetic association study and randomised, double-blind, phase 2a trial. Lancet Respir Med. 2021;9(11):1288-1298doi: 10.1016/S2213-2600(21)00167-3.
Rabe, K. F., Celli, B. R., Wechsler, M. E., Abdulai, R. M., Luo, X., Boomsma, M. M., Staudinger, H., Horowitz, J. E., Baras, A., Ferreira, M. A., Ruddy, M. K., Nivens, M. C., Amin, N., Weinreich, D. M., Yancopoulos, G. D., & Goulaouic, H. (2021). Safety and efficacy of itepekimab in patients with moderate-to-severe COPD: a genetic association study and randomised, double-blind, phase 2a trial. The Lancet. Respiratory medicine, 9(11), 1288-1298. https://doi.org/10.1016/S2213-2600(21)00167-3
Rabe, Klaus F, et al. "Safety and efficacy of itepekimab in patients with moderate-to-severe COPD: a genetic association study and randomised, double-blind, phase 2a trial." The Lancet. Respiratory medicine vol. 9,11 (2021): 1288-1298. doi: https://doi.org/10.1016/S2213-2600(21)00167-3
Rabe KF, Celli BR, Wechsler ME, Abdulai RM, Luo X, Boomsma MM, Staudinger H, Horowitz JE, Baras A, Ferreira MA, Ruddy MK, Nivens MC, Amin N, Weinreich DM, Yancopoulos GD, Goulaouic H. Safety and efficacy of itepekimab in patients with moderate-to-severe COPD: a genetic association study and randomised, double-blind, phase 2a trial. Lancet Respir Med. 2021 Nov;9(11):1288-1298. doi: 10.1016/S2213-2600(21)00167-3. Epub 2021 Jul 21. PMID: 34302758.
Copy Download .nbib Format: NLM
Showing 157 to 163 of 163 entries